Calcineurin inhibitors for adult-onset Still's disease: a multicentre retrospective cohort study.

CONCLUSIONS: Our retrospective analysis suggested that CNI could be an effective and safe option for treating AOSD. PMID: 32083551 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32083551?dopt=Abstract

Source: Clinical and Experimental Rheumatology - February 24, 2020 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research